Effect of high-dose simvastatin on cognitive, neuropsychiatric, and health-related quality-of-life measures in secondary progressive multiple sclerosis: secondary analyses from the MS-STAT randomised, placebo-controlled trial
Chan, Dennis, PhD, Binks, Sophie, MRCP, Nicholas, Jennifer M, PhD, Frost, Chris, Prof, Cardoso, M Jorge, PhD, Ourselin, Sebastien, Prof, Wilkie, David, MA, Nicholas, Richard, PhD, Chataway, Jeremy, Dr
Published in Lancet neurology (01.08.2017)
Published in Lancet neurology (01.08.2017)
Get full text
Journal Article
Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial
Chataway, Jeremy, Dr, Schuerer, Nadine, PhD, Alsanousi, Ali, PhD, Chan, Dennis, PhD, MacManus, David, BSc, Hunter, Kelvin, Anderson, Val, PhD, Bangham, Charles R M, Prof, Clegg, Shona, BSc, Nielsen, Casper, PhD, Fox, Nick C, Prof, Wilkie, David, MA, Nicholas, Jennifer M, PhD, Calder, Virginia L, PhD, Greenwood, John, Prof, Frost, Chris, Prof, Nicholas, Richard, PhD
Published in The Lancet (British edition) (28.06.2014)
Published in The Lancet (British edition) (28.06.2014)
Get full text
Journal Article